Literature DB >> 15617864

Gene, gut and schizophrenia: the meeting point for the gene-environment interaction in developing schizophrenia.

J Wei1, Gwynneth P Hemmings.   

Abstract

Both schizophrenia and celiac disease involve a genetic component. Several lines of evidence have shown a genetic relationship between these two conditions. Celiac disease is characterized by damage to the microscopic finger-like projections called villi, which line the small intestine and play a significant role in digestion, due to an inflammatory condition caused by a reaction to wheat gluten or related rye and barley proteins. Celiac disease represents not only malabsorption leading to a poor nutritional condition but also an alteration of gut permeability. Individuals with a history of a childhood celiac condition have a raised risk of developing schizophrenia. Psychotic symptoms often occur in adult celiac disease. It can be hypothesized that apart from malnutrition, the meeting point for the gene-environment interaction may be an alteration in gut permeability, in which the gut may lose its capacity to block exogenous psychosis-causing substances that may enter the body thus causing the development of schizophrenia and other mental conditions. To support this hypothesis, the conditional test was conducted to look at the combined effect of the CLDN5 gene involved in forming permeability barriers and the DQB1 gene that has been found to be associated with celiac disease. The results demonstrate that these two genes possibly work together in conferring a susceptibility to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15617864     DOI: 10.1016/j.mehy.2004.08.011

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  12 in total

Review 1.  Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications.

Authors:  Monojit Debnath; Michael Berk
Journal:  Schizophr Bull       Date:  2014-04-07       Impact factor: 9.306

Review 2.  The Gut-Brain Axis, BDNF, NMDA and CNS Disorders.

Authors:  Raeesah Maqsood; Trevor W Stone
Journal:  Neurochem Res       Date:  2016-08-23       Impact factor: 3.996

Review 3.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

4.  Novel immune response to gluten in individuals with schizophrenia.

Authors:  Diana Samaroo; Faith Dickerson; Donald D Kasarda; Peter H R Green; Chiara Briani; Robert H Yolken; Armin Alaedini
Journal:  Schizophr Res       Date:  2009-09-11       Impact factor: 4.939

Review 5.  Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors.

Authors:  David Baumeister; Alice Russell; Carmine M Pariante; Valeria Mondelli
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-05-01       Impact factor: 4.328

6.  Psychosis and silent celiac disease in a down syndrome adolescent: a case report.

Authors:  Amparo Morant
Journal:  Case Rep Pediatr       Date:  2011-12-01

7.  Serum zonulin and claudin-5 levels in patients with schizophrenia.

Authors:  Ayşe Usta; Faruk Kılıç; Arif Demirdaş; Ümit Işık; Duygu Kumbul Doğuç; Mustafa Bozkurt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-06-20       Impact factor: 5.270

Review 8.  Schizophrenia, the gut microbiota, and new opportunities from optogenetic manipulations of the gut-brain axis.

Authors:  Enrico Patrono; Jan Svoboda; Aleš Stuchlík
Journal:  Behav Brain Funct       Date:  2021-06-22       Impact factor: 3.759

Review 9.  Gluten sensitivity presenting as a neuropsychiatric disorder.

Authors:  Stephen J Genuis; Rebecca A Lobo
Journal:  Gastroenterol Res Pract       Date:  2014-02-12       Impact factor: 2.260

Review 10.  Claudins in intestines: Distribution and functional significance in health and diseases.

Authors:  Zhe Lu; Lei Ding; Qun Lu; Yan-Hua Chen
Journal:  Tissue Barriers       Date:  2013-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.